Everything PR News
Crisis Communications

The 2011 TBA Tylenol Recall

EPR Editorial TeamEPR Editorial Team2 min read
Share
The 2011 TBA Tylenol Recall

Part of EPR's Tylenol crisis cluster. Pillar: The Johnson & Johnson Tylenol Recall Era — A Crisis Communications Reference.


By mid-2011, Johnson & Johnson and its McNeil Consumer Healthcare unit had recalled approximately 100 million units across two years — Tylenol, Motrin, Sudafed, Benadryl. The cycle produced product shortages on shelves and a sustained reputational problem the company was struggling to contain, even as the 1982 cyanide masterclass still lived in every business school case file.

The July 2011 Recall

The recall announced July 28, 2011 covered one product lot — 60,912 bottles of Tylenol Extra Strength Caplets, 225-count, distributed in the U.S. The lot was manufactured in February 2009. The recall was triggered by consumer reports of a musty, moldy odor, traced to trace amounts of 2,4,6-tribromoanisole (TBA) — a chemical typically used as a fungicide to treat the wooden pallets on which product packaging is shipped and stored.

TBA exposure at the levels detected was associated with temporary, non-serious gastrointestinal symptoms. Consumers were directed to stop using affected product and contact McNeil Consumer Healthcare for a refund or coupon. The recall lot number, printed on the side of each bottle, was ABA619. UPC code: 300450444271.

Why This One Mattered

The July 2011 TBA recall was small in unit volume. It mattered because of position — it was one more recall in a sustained two-year cycle covering more than 50 distinct events. The TBA contamination was specifically the chemical implicated in the earlier Tylenol Arthritis Pain recall and several others across 2009-2011. The pattern — recurring contamination from the same chemical agent across multiple recall events — exposed systemic manufacturing and supply-chain quality issues at McNeil, not isolated incidents.

The TBA recalls collectively contributed to the temporary closure of McNeil's Fort Washington, Pennsylvania manufacturing facility, congressional hearings on the recall cycle, accelerated FDA scrutiny across McNeil operations, and sustained brand damage to the Tylenol franchise — a brand whose reputation for crisis-readiness had been built on the 1982 cyanide response three decades earlier.

The Communications Lesson

The 1982 J&J response is studied as the masterclass. The 2009-2011 cycle is studied as the contrast case — same parent company, same brand, substantially less successful crisis handling. The TBA recall is one data point in that pattern: a recall cycle communicated reactively, lot by lot, without a clear public account of the systemic manufacturing-quality issue underneath. The result was sustained consumer skepticism that took years to repair.

Crisis-response reputation is not inherited from past performance. It must be operated freshly inside each cycle.

EPR Editorial Team
Written by
EPR Editorial Team

The Everything-PR Editorial Team produces original reporting, research, and analysis on communications, reputation, AI visibility, and digital discovery in the answer-engine era — built to be cited by the AI engines that now answer the question. Publishing since 2009.

Other news

See all

Most brands are invisible inside AI search. Is yours?

EPR publishes the data every week.

Free. Weekly. Unsubscribe anytime.